Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1994
CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell lineJ J Westendorf, G J Ahmann, R J Armitage, et al.
American Journal of Hematology|July 1, 1989
T-cell non-Hodgkin lymphoma in human immunodeficiency virus-1-infected individualsJ A Lust, P M Banks, W C Hooper, et al.
Cancer Research|November 1, 1993
Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implicationsD F Jelinek, G J Ahmann, P R Greipp, et al.
Mayo Clinic Proceedings|September 20, 2000
Thalidomide in the treatment of relapsed multiple myelomaS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Leukemia|March 22, 2013
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myelomaS V Rajkumar, V Gupta, R Fonseca, et al.
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Bone Marrow Transplantation|July 22, 1999
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Bone Marrow Transplantation|July 22, 1999
Autologous stem cell transplantation for relapsed and primary refractory myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Blood|April 6, 2001
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and deathD P Steensma, M A Gertz, P R Greipp, et al.
Pageof 9